Fount

Fount sells small-batch, plant-based supplements and functional beverages sold in single-serve glass vials and refill cartons. SKUs cluster around gut, immunity, sleep and skin support; prices run $45–$90 per 14- to 30-day cycle, placing the brand in the premium tier. All commerce is direct-to-consumer through fount.bio; no retail partners or Amazon storefront exist. The company formulates with clinically backed, trademarked botanicals—think saffron extract for mood or post-biotic yeast for microbiome balance—and publishes third-party COAs for every lot. Its “travel-ready” glass ampoules are nitrogen-flushed for stability without preservatives, a packaging choice that has become shorthand for the brand on social feeds. Core buyers are 25-40-year-old urban professionals who track sleep and HRV, value clean-label sourcing and will pay extra for convenience and aesthetics. The brand speaks to optimization culture: minimal effort, maximal bio-feedback, Instagram-worthy rituals. Fount competes in the upscale, direct-to-consumer micro-supplement space against other tech-leaning wellness startups. It differentiates by merging beverage-grade flavoring with therapeutic dosing, glass single-serve delivery and transparent batch testing—positioning itself as a lifestyle upgrade rather than another pill bottle.